Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

NCT02187107 ·Status: COMPLETED ·Phase: PHASE2

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

NCT00008554 ·Status: UNKNOWN ·Phase: PHASE3

Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus

NCT03472326 ·Status: TERMINATED ·Phase: PHASE2

A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1

NCT06061081 ·Status: TERMINATED ·Phase: PHASE2

A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

NCT00363142 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)

NCT04003103 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

NCT00892437 ·Status: COMPLETED ·Phase: PHASE2

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002440 ·Status: COMPLETED ·Phase: PHASE2

Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

NCT06039579 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers

NCT03060447 ·Status: COMPLETED ·Phase: PHASE1

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

NCT00242879 ·Status: TERMINATED ·Phase: PHASE2

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

NCT00071760 ·Status: COMPLETED ·Phase: PHASE2

A Study of Viracept in HIV-Positive Women

NCT00002171 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants

NCT02275065 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection

NCT00002347 ·Status: COMPLETED ·Phase: PHASE2

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

NCT00297076 ·Status: TERMINATED ·Phase: PHASE3

3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

NCT04250636 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

NCT00002213 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

NCT00081588 ·Status: COMPLETED ·Phase: PHASE2

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

NCT00959894 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

NCT01638650 ·Status: COMPLETED ·Phase: PHASE1

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

NCT00001085 ·Status: COMPLETED ·Phase: PHASE2

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

NCT00393120 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of 141W94 and Indinavir in HIV-Infected Patients

NCT00002202 ·Status: COMPLETED ·Phase: PHASE3

3BNC117 and 10-1074 in ART-treated Individuals

NCT03526848 ·Status: COMPLETED ·Phase: PHASE1